RxSight Inc [RXST] stock is trading at $9.79, up 1.24%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RXST shares have gain 2.30% over the last week, with a monthly amount drifted -21.81%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RxSight Inc [NASDAQ: RXST] stock has seen the most recent analyst activity on July 15, 2025, when Morgan Stanley downgraded its rating to a Equal-Weight but kept the price target unchanged to $9 for it. Previously, Jefferies downgraded its rating to Hold on July 10, 2025, and kept the price target unchanged to $9. On July 09, 2025, downgrade downgraded it’s rating to Equal Weight but maintained its price target of $9 on the stock. Oppenheimer downgraded its rating to a Perform. BTIG Research downgraded its rating to a Neutral. Wells Fargo upgraded its rating to Overweight for this stock on May 19, 2025, but kept the price target unchanged to $25. In a note dated April 15, 2025, Piper Sandler initiated an Neutral rating and provided a target price of $18 on this stock.
RxSight Inc [RXST] stock has fluctuated between $6.32 and $34.71 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. RxSight Inc [NASDAQ: RXST] shares were valued at $9.79 at the most recent close of the market. An investor can expect a potential return of 2.15% based on the average RXST price forecast.
Analyzing the RXST fundamentals
RxSight Inc [NASDAQ:RXST] reported sales of 142.09M for the trailing twelve months, which represents a drop of -14.09%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -0.32%, Pretax Profit Margin comes in at -0.25%, and Net Profit Margin reading is -0.25%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.13 and Total Capital is -0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, RxSight Inc’s Current Ratio is 12.74. Also, the Quick Ratio is 11.44, while the Cash Ratio stands at 1.33. Considering the valuation of this stock, the price to sales ratio is 2.83, the price to book ratio is 1.46.
Transactions by insiders
Recent insider trading involved Fountain Tamara, Director, that happened on Mar 12 ’25 when 7000.0 shares were sold. Director, TAMARA R FOUNTAIN completed a deal on Mar 12 ’25 to buy 7000.0 shares. Meanwhile, Director Maniar Shweta sold 3519.0 shares on Jan 22 ’25.
